[Efficacy of different doses and timing of tranexamic acid in major orthopedic surgeries: a randomized trial]
Ravi Saravanan, Rajagopalan Venkatraman, Krishnamoorthy Karthik, Anand Pushparani, Ravi Saravanan, Rajagopalan Venkatraman, Krishnamoorthy Karthik, Anand Pushparani
Abstract
Background: Tranexamic acid was studied in four different dosage regimens and their efficacy was compared for perioperative blood loss reduction, blood transfusion requirements and deep vein thrombosis (DVT) complication.
Methods: Two hundred patients undergoing major orthopedic procedures were divided into five groups containing 40 patients each: Placebo, low dose (bolus 10 mg kg−1), low dose + maintenance (bolus 10 mg kg−1 + maintenance 1 mg kg−1 hr−1), high dose (bolus 30 mg kg−1) and high dose + maintenance (bolus 30 mg kg−1 + maintenance 3 mg kg−1 hr−1). Surgical blood loss was measured intraoperatively and drains collection in the first 24 hours postoperatively. Blood transfusion was done when hematocrit falls less than 25%. DVT screening was done in the postoperative period.
Results: The intraoperative blood loss was 440 ± 207.54 mL in the placebo group, 412.5 ± 208.21 mL in the low dose group, 290 ± 149.6 ml in the low dose plus maintenance group, 332.5 ± 162.33 mL in the high dose group and 240.7 ± 88.15 mL in the high dose maintenance group (p < 0.001). The reduction in postoperative blood loss in the drain for first 24 hours was 80 ± 44.44 mL in the placebo group, 89.88 ± 44.87 mL in the low dose group, 56.7 ± 29.12 mL in the low dose plus maintenance group, 77.9 ± 35.74 mL in the high dose group and 46.7 ± 19.9 mL in the high dose maintenance group (p < 0.001). DVT was not encountered in any patient.
Conclusion: Tranexamic acid was most effective in reducing surgical blood loss and blood transfusion requirements in a low dose + maintenance group.
Keywords: Blood loss; Blood transfusion; Dosage; Dosagem; Perda sanguínea; Posologia; Timing; Tranexamic acid; Transfusão de sangue; Ácido tranexâmico.
Copyright © 2020 Sociedade Brasileira de Anestesiologia. Publicado por Elsevier Editora Ltda. All rights reserved.
Figures
References
- Irisson E., Hémon Y., Pauly V., et al. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res. 2012;98:477–483.
- Ker K., Edwards P., Perel P., et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.
- Zufferey P.J., Lanoiselée J., Chapelle C., et al. investigators of the PeriOpeRative Tranexamic acid in hip arthroplasty (PORTO) Study Intravenous tranexamic acid bolus plus infusion is not more effective than a single bolus in primary hip arthroplasty: a randomized controlled trial. Anesthesiology. 2017;127:413–422.
- Aytuluk H.G., Yaka H.O. Tranexamic acid is effective in lower doses with infusion in total knee arthroplasty. Acta Orthop Traumatol Turc. 2019;53:81–85.
- Maniar R.N., Kumar G., Nayak R.M. Most effective regimen of tranexamic acid in knee arthroplasty – a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012;470:2605–2612.
- McHugh S.M., Kolarczyk L., Lang R.S., et al. A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery. Indian J Anaesth. 2016;60:94–101.
- Zimmerman L.H. Causes and consequences of critical bleeding and mechanisms of blood coagulation. Pharmacotherapy. 2007;27:45–56.
- Thipparampall A.K., Gurajala I., Gopinath R. The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery. Indian J Anaesth. 2017;61:235–239.
- Goobie S.M., Meier P.M., Pereira L.M., et al. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A double-blind, placebo-controlled trial. Anesthesiology. 2011;114:862–871.
- Thiagarajamurthy S., Levine A., Dunning J. Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2004;3:489–494.
- Fawzy H., Elmistekawy E., Bonneau D., et al. Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss?. A randomized controlled trial. J Cardiothorac Surg. 2009;4:25.
- Choi W.S., Irwin M.G., Samman N. The effect of tranexamic acid on blood loss during orthognathic surgery: A randomized controlled trial. J Oral Maxillofac Surg. 2009;67:125–133.
- Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care. 2003;31:529–537.
- Gill J.B., Chin Y., Levin A., et al. The use of antifibrinolytic agents in spine surgery. A meta-analysis. J Bone Joint Surg Am. 2008;90:2399–2407.
- Huang F., Wu D., Ma G., et al. The use of tranexamic acid to reduce blood loss and transfusion in major orthopaedic surgery: a meta-analysis. J Surg Res. 2014;186:318–327.
Source: PubMed